FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15989711000001100: Citalopram 20mg tablets (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56591301000001117 Citalopram 20mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56591401000001113 Citalopram 20mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely citalopram (as citalopram hydrobromide) 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has active ingredient Citalopram hydrobromide false Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Citalopram hydrobromide true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Citalopram true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Citalopram 20mg tablets (Bristol Laboratories Ltd) Has basis of strength substance Citalopram true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Citalopram 20mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Citalopram 20mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start